OBJECTIVE: Psoriatic arthritis (PsA) is often poorly responsive to 2nd line antirheumatic drug therapy. Sulfasalazine has recently gained wide acceptance in the treatment of rheumatoid arthritis ...
Sulfasalazine is not approved for treating PsA; but is approved for RA treatment. A double-blind, placebo- controlled, randomized trial evaluated sulfasalazine (2,000 mg/day) versus placebo ...
Non-steroidal anti-inflammatory drugs (NSAIDs) and traditional disease modifying antirheumatic drugs (DMARDs) are widely used in the treatment of psoriatic arthritis (PsA), but ... antimalarials, ...
Psoriatic arthritis is an autoimmune disease that ... The most commonly used is methotrexate, followed by leflunomide and ...
Psoriatic Arthritis Long-term Assessment of Clinical Efficacy 1 ... Patients on background concurrent DMARDs continued stable doses (methotrexate, leflunomide and/or sulfasalazine). Primary outcome ...
Reactive arthritis is treated similarly to ankylosing spondylitis and psoriatic arthritis, with sulfasalazine and methotrexate, and, if necessary, TNF-alpha blockers. If there is any clue to infection ...
Psoriatic arthritis (PsA) is an autoimmune disease ... Another DMARD approved for juvenile PsA is Azulfidine (sulfasalazine). Biologics are medicines that target specific proteins in the immune ...
Although effective against other rheumatic diseases, disease-modifying antirheumatic drugs (DMARDs), such as sulfasalazine ... effective in psoriatic arthritis and rheumatoid arthritris, in ...
Are you searching for effective medications to treat 'Psoriatic Arthritis'? This comprehensive guide provides the latest information on medications-both generic and branded-that are essential for ...